{"prompt": "['Study: Neuroendocrine Tumors - Patient Reported Outcomes (NET-PRO)', 'Document Title: \"NETPRO Protocol.pdf', 'Date: Approved by IRB on 2022-05-06', 'Uploaded: 2022-05-11', 'NCT Number: NCT05064150']['NET-PRO Protocol v1.3', 'April 2022', 'NET-', 'PR', 'Neuroendocrine Tumors - Patient Reported Outcomes', 'NET-PRO Study Protocol', 'Date: April 2022', 'Version: 1.3', 'Sponsor: Patient-Centered Outcomes Research Institute', 'Contract Number: RD-2020C2-20329', 'Project Period: 7/1/2021-6/30/2024 (36 months)', \"Contact Principal Investigator: Michael O'Rorke, S451, Department of Epidemiology, University of Iowa,\", 'College of Public Health, 145 N Riverside Dr, Iowa City, IA 52242,', '+1 319 384-1560', 'michael-ororke@uiowa.edu', 'Project Coordinator: Brian Gryzlak, S414 CPHB, University of Iowa, lowa City, IA 52242', '+1 319 335-8218', 'brian-gryzlak@uiowa.edu', 'Partnering Patient Advocacy Organizations:', 'Northern California CarciNET Community (NorCal CarciNET) https://norcalcarcinet.org/', 'The Neuroendocrine Cancer Awareness Network (NCAN) https://www.netcancerawareness.org', 'The Neuroendocrine Tumor Research Foundation (NETRF) https://netrf.org/', 'The Healing NET Foundation https://www.thehealingnet.org/', 'Participating PCORI Networks & Sites', 'GPC (6): University of Iowa, Allina Health, University of Kansas Medical Center, Medical College of', 'Wisconsin, University of Texas Southwestern Medical Center, University of Utah', 'OneFlorida (1): University of Florida', 'STAR (4): Medical University of South Carolina, University of North Carolina at Chapel Hill, Vanderbilt', 'University Medical Center, Mayo Clinic', 'PATH (3): University of Pittsburgh Medical Center, Ohio State University, University of Michigan', '1']['NET-PRO Protocol v1.3', 'April 2022', 'Protocol Version and Amendment Tracking', 'Version Number/Amendment', 'Date', 'Summary of changes', 'Original Protocol, Version 1.0', '10/22/2021', 'Revision, Version 1.1', '4/7/2022', 'Removed appendices; added EMR messaging as', 'recruitment method (excluding UIHC); revisions to:', 'background, study measures and outcomes, and', 'computable phenotype for identifying patients; and', 'changes to recruitment processes and subject payments.', 'Revision, Version 1.2', '4/13/2022', 'Added NET Registry at UIOWA as recruitment source;', 'clarified data sources to be used for identifying eligible', 'patients.', 'Revision, Version 1.3', '4/22/2022', 'Clarified recruitment and survey follow up contact', 'procedures.', '2']\n\n###\n\n", "completion": "END"}